Meta-analysis of 7 RCTs (2,510 patients) with resectable gastric or GEJ adenocarcinoma: adding ICIs to perioperative chemotherapy improved pCR (17.6% vs 6.1%), EFS (HR 0.76) and OS (HR 0.82), with no significant rise in grade ≥3 TRAEs; no benefit in PD-L1 negative.
Meta-analysisn = 2,510
Omori et al. Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis